BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29461957)

  • 1. Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study.
    van Pelt PA; Dolhain RJEM; Kruize AA; Ammerlaan JJW; Hazes JW; Bijlsma JWJ; Wulffraat NM
    Clin Exp Rheumatol; 2018; 36(1):163-168. PubMed ID: 29461957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
    Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
    Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and perceived relevance of health-related Internet sites and online contact with peers among young people with juvenile idiopathic arthritis.
    van Pelt PA; Drossaert CH; Kruize AA; Huisman J; Dolhain RJ; Wulffraat NM
    Rheumatology (Oxford); 2015 Oct; 54(10):1833-41. PubMed ID: 25998449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of transition phase patients with juvenile idiopathic arthritis.
    Relas H; Luosujärvi R; Kosola S
    Mod Rheumatol; 2018 Sep; 28(5):832-837. PubMed ID: 29251024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.
    Taxter AJ; Wileyto EP; Behrens EM; Weiss PF
    J Rheumatol; 2015 Oct; 42(10):1914-21. PubMed ID: 26329337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
    Rocha FAC; Landim JIVD; Aguiar MG; Accioly JPE; Lechiu CN; Costa LHA; Júnior CNR; da Rocha LN; Rocha HAL
    Rheumatol Int; 2019 Jan; 39(1):67-71. PubMed ID: 30101369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience.
    Mikola K; Rebane K; Arnstad ED; Berntson L; Fasth A; Glerup M; Herlin T; Kautiainen H; Nielsen S; Nordal E; Peltoniemi S; Rygg M; Rypdal V; Zak M; Aalto K
    Pediatr Rheumatol Online J; 2022 Oct; 20(1):84. PubMed ID: 36182898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.